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Abstract 
Protein phosphatase 2A (PP2A) is a major protein phosphatase with important cell func-
tions. Known and utilized as a potent inhibitor of PP2A, microcystin-LR (MCLR) targets 
PP2A as a core element that affects numerous cellular mechanisms. But apart from direct 
inhibition, the exact effect of MCLR on PP2A in cell is largely unknown, specifically with 
regard to cellular response and autoregulation. Here, we show that a low concentration 
of MCLR stimulates, rather than inhibits, PP2A activity in HEK293 cells. Immunoprecip-
itation and immunofluorescence assays reveal that the catalytic subunit and a regulatory 
subunit of PP2A, termed α4, dissociate from inactive complex upon MCLR exposure, 
suggesting that the released catalytic subunit regains activity and thereby compensates 
the activity loss. At high concentrations of MCLR, PP2A activity decreases along with 
dissociation of the core enzyme and altered post-translational modification of its catalytic 
subunit. In addition, the dissociation of α4 and PP2A may contribute to destabilization of 
HEK293 cells cytoskeleton architecture, detachment to extracellular matrix and further 
anoikis.  Our  data  provide  a  novel  PP2A  upregulation  mechanism  and  challenge  the 
recognition of MCLR only as a PP2A inhibitor in cells. 
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Introduction 
Microcystin-LR (MCLR) is one of the most toxic 
secondary  metabolites  produced  by  freshwater  cya-
nobacteria. Because of its presence in aquatic blooms, 
the  molecule  causes  a  world-wide  environmental 
problem. MCLR in drinking water is implicated in the 
development of liver cancer and damage to multiple 
organs  including  liver,  kidney,  intestines  and  brain 
[1]. The mechanism of MCLR toxicity has been widely 
accepted  as  it  inhibits  two  important  protein  phos-
phatases (PPs), PP1 and PP2A, as well as causes oxi-
dative stress, in cell [2-3]. Moreover, proteomic stud-
ies by our group and others have found that MCLR 
and MCRR, another microcystin that is also a potent 
inhibitor of PPs, comprehensively affect various cel-
lular  mechanisms,  which  are  mostly  regulated  by 
PP2A  [4-6].  Indeed,  it  is  acknowledgeable  that  the 
effect  of  MCLR  follows  a  “MCLR  –  PPs  –  cellular 
mechanism” paradigm. However, cellular autoregu-
lation of PPs in response to MCLR is a missing part 
and still remains elusive. 
Protein phosphatase 2A (PP2A) is a major pro-
tein phosphatase in the cell that is involved in diverse 
cellular processes including RNA transcription, DNA 
repair, cell proliferation and apoptosis [7-9]. Typical-
ly, the PP2A holoenzyme is comprised of a 36-kDa 
catalytic subunit (PP2A/C), a 65-kDa scaffold subunit 
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(PP2A/A), and one of a variety of regulatory subunits 
(PP2A/B). The regulatory subunit binds to the core 
enzyme (AC) to form the holoenzyme and thus de-
termines  the  specific  functions  of  PP2A  [10].  PP2A 
activity is mainly regulated by its interacting proteins, 
its  regulatory  subunits  and  the  post-translational 
modification of PP2A/C. PP2A/C is also a target of 
numerous toxins including MCLR, possibly because it 
is one of the most evolutionarily conserved enzymes 
in eukaryotic cells [2]. It is clear so far that the cova-
lent binding of MCLR directly and potently inhibits 
PP2A/C  catalytic  activity.  But  we  also  previously 
reported that MCLR upregulated the protein level of 
PP2A/A, which may suggest a more intricate effect of 
MCLR  on  PP2A  in  cell  [11].  When  considering  the 
post-translational modification of PP2A as well as the 
interaction among its subunits, the effect of MCLR on 
PP2A could become even more complicated. 
Interestingly, a fraction of PP2A/C was found to 
form a complex with the α4 protein, the homolog of 
Tap42  in  yeast.  The  amount  of  Tap42  associated 
PP2A/C was predicted to be about 2% of the whole 
PP2A/C pool. However, there were only 28% shared 
sequence  identity  between  α4  and  Tap42,  thus  the 
amount of α4 associated PP2A/C was still unknown 
to our knowledge [12]. It is notable that the complex 
of  α4  and  PP2A/C  is  independent  of  the  A  and  B 
subunits, as the binding sites between α4 and PP2A/C 
partially overlap with that of the PP2A A and C sub-
units [13]. Classically, the α4 binding form of PP2A is 
believed to either be inactive or show low phospha-
tase catalytic activity [14-15]. However, α4 has been 
reported  to  have  important  functions  regulating 
PP2A, as it manages PP2A core enzyme assembly and 
PP2A/C ubiquitination [12, 16-17]. Moreover, α4 was 
reported  to  implement  many  cellular  functions 
through PP2A, including control of cytoskeleton ar-
chitecture and anti-anoikis/apoptosis [18-21]. There-
by, when PP2A is under the insult of MCLR, whether 
α4, the essential PP2A regulator in cell, participates in 
the cellular regulation of PP2A is an interesting ques-
tion.  
In the present study, we used HEK293 (Human 
Embryonic  Kidney  293)  cells  because  kidney  is  an 
important  target  organ  of  MCLR;  while  the  ne-
phrotoxicity of MCLR is much less understood than 
its hepatotoxicity. We tested the PP2A activity as well 
as  other  biochemical  features  of  PP2A  in  HEK293 
cells,  together  with  cellular  behavior  after  different 
concentration of MCLR treatment. Surprisingly, PP2A 
activity in HEK293 cells was stimulated, not inhibited, 
by low-concentration MCLR treatment, which may be 
due  to  the  dissociation  of  α4  and  PP2A/C.  Under 
high-concentration  MCLR  exposure,  PP2A  activity 
decreased along with the disruption of the core en-
zyme and alternation of post-translational modifica-
tions on the C subunit. Moreover, the dissociation of 
α4 and PP2A/C is correlated with disruption of cyto-
skeleton,  cell  detachment  and  possible  anoikis  in-
duced by MCLR, suggesting the consequences after α4 
and PP2A/C dissociation. 
Materials and Methods 
HEK293 Cell Culture and Treatment 
HEK293 cell line was purchased from Cellbank 
of  Chinese  Academy  of  Sciences  (Catalog  No. 
GNHu18). HEK293 Cells were cultured in Dulbecco’s 
modified  Eagle’s  medium  supplemented  with  10% 
FBS, in flasks, dishes, or plates, with suitable inocu-
lum ratio according to the amount of cells needed in 
one experiment, at 37°C in a humidified atmosphere 
with 5% CO2. Cells were allowed to attach and grow 
for  24  h  before  the  media  was  replaced  with  fresh 
media containing MCLR (Alexis, Switzerland). MCLR 
was resolved and diluted precisely in order to keep 
the  treatment  concentrations  accurate.  At  cell  treat-
ment, the control groups of each assay were replaced 
with fresh media without MCLR. The beginning and 
ending of MCLR treatment were within the logarith-
mic  phase  of  cell  growth.  Prior  to  any  cell  lysate 
preparation,  cells  were  washed  twice  with  ice  cold 
PBS, harvested, and gently rinsed with PBS four times 
via pelleting in microtubes by centrifugation in order 
to fully remove MCLR in media. 
Western blotting 
The protein levels and post-translational modi-
fication  of  interested  proteins  were  tested  using 
Western blotting. Cell extracts were prepared in lysis 
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 15 mM 
EDTA, 0.1% TritonX-100, 1 mM PMSF,) with protease 
inhibitor  complex  (Roche)  on  ice  for  30  min.  After 
protein  concentration  was  detected  using  the  Brad-
ford method [22], 60 μg of cell extract were loaded on 
SDS-PAGE for electrophoresis and the gels produced 
were  transferred  to  nitrocellulose  membranes.  Pri-
mary antibodies applied at 4°C overnight were: an-
ti-PP2A/A mouse mAb (Cell Signaling Technology), 
anti-PP2A/C rabbit mAb (Cell Signaling Technology), 
anti-Caspase-3 rabbit mAb (Cell Signaling Technolo-
gy),  anti-p-Y307  PP2A/C  rabbit  mAb  (Abcam),  an-
ti-methyl-L309  PP2A/C  mouse  mAb  (Abcam),  an-
ti-Mid 1 rabbit poly Ab (Abcam), anti-α4 mouse mAb 
(Upstate),  anti-MCLR  mouse  mAb  (Alexis),  an-
ti-β-actin mouse mAb (Santa Cruz), anti-Bcl-2 rabbit 
mAb (Santa Cruz), anti-Bad rabbit mAb (Bioworld), 
and  anti-GAPDH  mouse  mAb  (KANGCHEN).  The Int. J. Biol. Sci. 2011, 7 
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concentration recommended by producers was used 
as  were  the  standard  Western  blotting  procedures. 
Figures  representing  three  independent  assays  are 
shown. Densitometric data were collected by Image J 
software  (National  Institutes  of  Health)  for  further 
statistical analysis. 
PP2A Activity Assay 
PP2A  activity  was  measured  by  two  methods, 
both  determine  the  amount  of  free  phosphate  by 
measuring the absorbance of a molybdate: malachite 
green:  phosphate  complex.  First  was  with  a  ser-
ine/threonine  phosphatase  assay  kit  (Promega). 
Briefly,  cells  were  collected  from  6  well  plates  and 
washed  before  lysis  on  ice  in  lysis  buffer  (50  mM 
Tris-HCl pH 7.5, 0.05% Triton X-100, 0.1 mM EDTA, 
0.5 mM PMSF, 0.05% β-mercaptoethanol, 10% glycer-
ol)  with  protease  inhibitor  complex  (Roche)  for  40 
min,  with vortex every 10 min. The cell lysate  was 
filtered through a Sephadex G25 column to remove 
free phosphate. Protein concentration was determined 
using the Bradford method. 2.5 μg of cell protein were 
distributed equally among the wells of a 96 well plates 
with  the  specific  peptide  substrate  RRA(pT)VA  in 
PP2A-specific reaction buffer (250 mM imidazole pH 
7.2, 1 mM EGTA, 0.1% β-mercaptoethanol, 0.5 mg/ml 
BSA) at 37°C for 18 min. After incubation,  50 μl of 
molybdate dye/additive mixture was added, and the 
color was allowed to develop for 20 min. The optical 
density of the samples was read using a 96-well plate 
reader at 630-nm. All determinations were performed 
in duplicate, and the absorbance of the reactions was 
corrected  by  determining  the  absorbance  of  control 
reactions  without  phosphoprotein  substrate.  The 
amount of phosphate released (pmol) was calculated 
from a standard curve (0–2000 pmol) and normalized 
using the controls. The second method was using an 
antibody  against  PP2A/C  to  immunoprecipitate 
PP2A/C  before  measuring  its  activity,  specifically 
[16]. Briefly, 300μg of total cell lysate from each group 
was prepared as described above. PP2A/C was pre-
cipitated from cell lysate using 3 μg of PP2A/C anti-
body (clone 1D6, Upstate) with rotation for 12 h at 
4°C, and then 40 μl of Protein A agarose beads were 
added  for  2  h  rotation  at  4°C.  Noteworthy,  this 
PP2A/C antibody does not block phosphatase activi-
ty.  PP2A  activity  was  measured  by  incubating  the 
immunoprecipitated  protein  with  the  substrate 
RRA(pT)VA for 5 min at 37°C, with 1000rpm shaking. 
Afterwards, 25 μl of reacted solution was mixed with 
100 μl molybdate dye/additive in a 96 well plate. The 
analysis of yielded free phosphate from each group 
was as previously described. Finally, the phosphatase 
activity  was  normalized  to  the  relative  amount  of 
immunoprecipitated PP2A/C  referring to the West-
ern blotting quantification analysis. Data were from 
three independent assays of each method. 
Immunoprecipitation 
Immunoprecipitation was used to test the inter-
action between interested proteins in this study. Cells 
were  collected  from  dishes  before  lysed  in  RIPA 
buffer  (Millipore)  with  0.05%  β-mercaptoethanol,  1 
mM PMSF and protease inhibitor complex (Roche) at 
4°C for 40 min. After 14000 x g centrifugation for 20 
min to precipitate the pellet, ~1 mg cell lysate from 
each group was incubated, with rotation, with 10 µl 
anti-PP2A/C  rabbit  monoclonal  antibody  (Cell  Sig-
naling Technology) at 4°C overnight. 100 µl Protein A 
agarose beads (Santa Cruz) were added and the mix-
ture  was  rotated  for  an  additional  3  h.  Beads  were 
washed four times with RIPA buffer and once with 
PBS, resuspended in SDS loading buffer and boiled 
prior to Western blotting. Three selected independent 
assays are shown. 
Immunofluorescence 
Immunofluorescence was used in this study to 
investigate  the  localization  of  interested  proteins. 
About 50% to 60% confluent cells on coverslips were 
washed by PBS, fixed with 4% formaldehyde 10 min 
and  blocked  with  10%  FBS/PBS  (v/v)  for  20  min. 
Cells  were  then  incubated  with  following  primary 
antibodies: anti-PP2A/C rabbit mAb (Cell Signaling 
Technology), anti-MCLR mouse mAb (Alexis), anti-α4 
mouse  mAb  (Upstate),  anti-vinculin  mouse  mAb 
(Abcam). Solutions were diluted to the recommended 
concentration in 0.1% saponin/FBS/PBS (w/v) at 4°C 
overnight.  After  washing  with  10%  FBS/PBS,  sec-
ondary antibodies of Alexa Fluor 488 goat anti-rabbit 
IgG conjugate and Alexa Fluor 549 goat anti-mouse 
IgG  conjugate  (Jackson  ImmunoResearch  Laborato-
ries) were applied. Nuclei and F-actin were visualized 
by  staining  with  DAPI  (Sigma)  and  Phallotoxins 
(Molecular Probes). Images were captured on a Zeiss 
microscope (LSM 510 META); figures representing 10 
randomly chosen fields are shown. 
Cell Detachment Assay 
Cell detachment assay was applied in this study 
to  measure  the  detachment  of  cells  after  MCLR 
treatment. Equal amounts of cells were seeded onto 
12-well  plates.  Each  experimental  group,  which 
would further be washed by PBS, corresponded to a 
control group. After treatment, cells in control groups 
were trypsinized and harvested in order to measure 
the total amount of cells. Cells in experimental groups 
were washed three times in PBS at room temperature Int. J. Biol. Sci. 2011, 7 
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and shaken gently for 10 s. Adherent cells were then 
trypsinized  and  harvested.  All  cell  samples  were 
counted  with  a  Beckman  Coulter  cell  counter.  The 
extent of cell detachment is defined as (the number of 
control group - the number of experimental group) / 
(the number of control group). In brief, cell detach-
ment was quantified by counting only adherent cells 
[23]. Data were from three independent assays. 
MTT assay 
MTT assay was used to test the changes of cel-
lular  viability  after  MCLR  treatment.  HEK293  cells 
were seeded at equal number in 24 well plates. After 
treatment,  media  ware  replaced  with  fresh  media 
containing  0.5mg/ml  3-  (4,5-dimethylthiazol-2-yl)- 
2,5-diphenyltetrazolium bromide (MTT), and further 
incubated  for  4  h.  Following  aspirating  the  culture 
medium, the resulting formazan was dissolved with 
dimethylsulfoxide. Plates were placed on a shaker for 
10 min and read immediately at 490 nm with a mi-
croplate  reader.  Data  were  from  three  independent 
assays. 
Statistical analysis 
All  data  are  presented  as  the  mean  ±SD  from 
three independent experiments (n=3). Pairwise com-
parisons between means were tested by a Student’s 
t-test, two-tailed analysis. n.s. not significant; *,p<0.05; 
**,p<0.01; and ***,p<0.001.  
Results 
MCLR exists in HEK293 cells associated with 
PP2A C subunit  
Recent studies report that a group of hepatocyte 
uptake transporters termed organic anion transport-
ing  polypeptides  (OATPs)  are  crucial  for  MCLR 
transfer into cells, and question the presence of MCLR 
in  non-OATP  cells  [24-25].  To  our  knowledge,  few 
immortalized  kidney  cell  line  expresses  OATP,  not 
HEK293 cells as well. Therefore as premise, we first 
verified  the  presence  of  MCLR  in  non-transfected 
HEK293 cells by Western blotting with an antibody 
against  MCLR.  HEK293  cells  were  treated  with  0.5 
μM–10 μM MCLR for 24 hours, and MCLR was then 
carefully removed from the cultures as described in 
Experimental  Procedures.  As  shown  in  Fig.  1A,  the 
bands of proteins recognized by anti-MCLR antibody 
showed  a  dose-dependent  increase  at  the  ladder  of 
molecular weight of about 30 kDa to 39kDa, similar to 
that seen in OATP-positive cells [24]. As the molecular 
of PP2A/C is about 36 kDa, the result possibly sug-
gested the binding of MCLR to PP2A/C. To substan-
tiate the prediction, Western blotting was applied at 
one membrane using antibodies against MCLR and 
PP2A/C,  each  with  a  different  IRDye  conjunct  sec-
ondary  antibody.  As  shown  in  Fig.  1B,  there  were 
up-shift bands about 1 kDa above the 36 kDa band in 
MCLR-treated groups. Because the molecular weight 
of MCLR is about 995Da, these bands might suggest 
the MCLR-conjunct bands of PP2A/C. Notably, these 
up-shift bands also showed a co-migration with the 
bands of MCLR, which strongly suggest the binding 
of MCLR and PP2A/C. Also, there were a portion of 
bands  probed  by  anti-MCLR  antibody  that  did  not 
overlap with the bands of PP2A/C, suggesting other 
possible MCLR-bound proteins tested. An immuno-
fluorescence assay (Fig. 1C) probed both PP2A/C and 
MCLR. Though a small amount of non-specific bind-
ing  was  detected,  the  merged  images  show  that 
binding  of  MCLR  and  PP2A/C  increases  in  a 
dose-dependent  manner,  consistent  with  the  results 
above.  Although  pinocytosis  rather  than  active 
transport may be responsible for MCLR uptake, and 
the quantity of MCLR in HEK293 cells could be much 
lower  than  OATP-positive  cells,  the  presence  of 
MCLR in non-OATP HEK293 cells is clear. 
PP2A activity undergoes opposite change with 
alternations of the protein level and modifica-
tion of its subunits  
To measure the effect of MCLR on PP2A in the 
cell,  HEK293  cells  were  exposed  to  1  μM–10  μM 
MCLR  for  24  hours  before  being  harvested.  The 
MCLR  concentration  and  incubation  time  were  de-
cided  according  to  previous  studies  performed  by 
our, and other, groups [26-27].  
To our surprise, PP2A activity increased at low 
concentrations  of  MCLR.  After  peaking  at  a  2  μM 
concentration  at  a  rise  of  about  30%,  PP2A  activity 
decreased in a dose-dependent manner to about 20% 
for a 10 μM concentration (Fig. 2A), measured by a 
Promega kit. To confirm this result, we tested PP2A 
activity at 2μM and 10μM MCLR treatment, and con-
trol,  by  an  immunoprecipitation  phosphatase  assay 
method.  Shown  in  Fig.  2B,  PP2A  activity  changed 
consistently  to  the  above  data.  As  shown  above, 
MCLR is present in HEK293 cells through the whole 
range of concentrations used in the PP2A activity as-
say.  Thus,  rather  than  simply  inhibition,  the  data 
might suggest a more complicated effect of MCLR on 
PP2A in HEK293 cells. 
We  tried  to  explain  the  opposing  activities  of 
PP2A on the protein level of core enzyme. As shown 
in  Fig.  2C,  PP2A/A  maintains  its  protein  level 
through  the  whole  range  of  MCLR  dosing.  At  the 
treatment of MCLR, the protein level of PP2A/C did 
not show a significant change. At a high concentration Int. J. Biol. Sci. 2011, 7 
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(5 μM and above) of MCLR, a band, which increases 
in a dose-dependent manner, is found approximately 
1 kDa above the target 36 kDa. Conversely, the band 
at 36KDa displayed a dose-dependent decrease. The 
result  might  thereby,  reconfirm  the  existence  of 
MCLR in HEK293 cells. However, it could only ex-
plain the decrease in PP2A activity, not the increase at 
low concentrations of MCLR.  
We  next  investigated  the  post-translational 
modification of PP2A/C, because reversible methyla-
tion and phosphorylation of its carboxy-terminal tail 
had  been  reported  to  regulate  its  catalytic  activity: 
phosphorylation  of PP2A/C at Tyr307 decreases its 
catalytic  activity  and  methylation  of  PP2A/C  at 
Leu309  affects  its  affinity  to  regulatory  subunits. 
Therefore,  antibodies  against  phosphorylation  and 
methylation of PP2A/C at these exact sites were ap-
plied  via  Western  blotting.  However,  even  if 
post-translational  modification  regulates  catalytic 
activity, the changes in PP2A activity can still only be 
partially  explained  by  the  decrease,  rather  than  the 
increase.  As  shown  in  Fig.  2B,  the  proportion  of 
phosphorylated  PP2A/C  slightly  increased  and 
methylated PP2A/C decreased at high concentrations 
(5  μM  and  above)  of  MCLR,  while  both  remained 
constant in the 2 μM MCLR group. In addition, the 
anti-methylated-PP2A/C  antibody  almost  failed  to 
detect  the  up-shift  bands.  Because  MCLR  modifica-
tion is more likely to be the reason for the loss of PP2A 
activity, we further discussed the theory in Discussion. 
 
 
Figure 1. MCLR is associated with the PP2A C subunit in the cell. HEK293 cells were treated with MCLR at varying 
concentrations for 24 h. (A) Cell lysate was examined by Western blotting with an antibody against MCLR. (B) Cell 
lysate was tested by Western blotting with antibodies against MCLR (red) and PP2A/C (green) on one nitrocellulose 
membrane. Each antibody was further probed by IRDye 680 conjugated goat anti-mouse or IRDye 800CW conjugated 
goat anti-rabbit secondary antibody (LI-COR) before scanned. Merged imaged showed the co-migration of MCLR and 
PP2A/C. (C) Immunofluorescence assay of MCLR (red), PP2A/C (green) and nuclei (blue).  Int. J. Biol. Sci. 2011, 7 
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Figure  2.  PP2A  shows  opposing  activity  with  diffuse  alternations  of  its  core  enzyme  protein  level  and 
post-translational modification under MCLR treatment. HEK293 cells were exposed to varying concentrations of 
MCLR for 24 h before PP2A analysis. (A) PP2A activity was measured with a Promega serine/threonine phosphatase kit 
assay. Data represent means ±SD (n=3) *, p<0.05; **, p<0.01; ***, p<0.001 compared with control. (B) PP2A activity 
was measured by PP2A immunoprecipitation phosphatase assay. Data represent means ±SD (n=3) *, p<0.05; **, p<0.01 
compared with control. (C) PP2A core enzyme subunits A and C, including phosphorylated and methylated subunit C, 
were examined by Western blotting, where β-actin was used as loading control. (D) Ubiquitination of PP2A/C was 
captured by Western blotting with an antibody against PP2A/C at different exposure time (short: 1min, long: 10min). 
(E) Immunoprecipitation assay was applied in HEK293 cell lysate using an anti-PP2A/C antibody. The association of 
PP2A/C with Mid 1 form precipitated material was detected by Western blotting.  
 
Finally, we tested the ubiquitination of PP2A/C 
after  MCLR  exposure,  because  ubiquitination  of 
PP2A/C has been predicted to be related with its de-
creased  phosphatase  activity  [28].  We  adjust  the 
amount  of  loaded  protein  according  to  previous 
Western  blotting  assay  to  keep  the  total  amount  of 
PP2A/C  approximately  the  same,  as  shown  in 
shot-time exposure result (Fig. 2D left). At long-time 
exposure (Fig. 2D right), we captured a slight but ob-
servable ladder of band, differing in molecular mass 
about  8  kDa  above  the  major  band,  which  might 
suggest  the  monoubiquitination  of  PP2A/C  [16-17]. 
Observably, this band decreased at 2 μM and 10 μM 
groups. Because ubiquitination of PP2A/C has been 
predicted to decrease PP2A activity, the loss of ubiq-
uitination might suggest a possible correlation with 
the  upregulation  of  PP2A  activity  at  low  dose  of 
MCLR  treatment.  We  further  tried  to  reinforce  the Int. J. Biol. Sci. 2011, 7 
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ubiquitination  result  using  immunoprecipitation  to 
test the interaction between PP2A/C and its E3 ubiq-
uitin  ligase  Mid  1,  which  mediate  the  binding  of 
PP2A/C  and  ubiquitin.  As  shown  in  Fig.  2E,  the 
binding of PP2A/C and Mid 1 decreased in both 2 μM 
and 10 μM groups, which is consistent with the pre-
vious  result.  Although  the  relationship  between 
ubiquitination of PP2A/C and its activity is not clear 
yet,  and  our  data  might,  therefore,  only  suggest  a 
tenuous link between them, it gave us a hint to look 
into further evidence to explain the opposing PP2A 
activity change.  
α4 and PP2A C subunit dissociate under MCLR 
treatment  
Because  the  binding  of  PP2A/C  and  Mid  1  is 
reported to be managed by a special PP2A regulatory 
subunit, termed α4 [17], which is also an important 
PP2A activity regulator under cellular stress, we next 
focused our study to the interaction between PP2A/C 
and α4. To address the role of α4 in the regulation of 
PP2A in HEK293 cells with MCLR treatment, we at 
first examined the protein level of α4 after 2 μM–10 
μM  MCLR  exposure.  As  shown  in  Fig.  3A,  α4  was 
constantly expressed across all concentrations. Next, 
the  binding  of  α4  and  PP2A/C  was  measured  by 
immunoprecipitation. As shown in Fig. 3B, the bind-
ing of α4 and PP2A/C decreased in a MCLR concen-
tration-dependent manner; about 60% of the original 
complex dissociated at 2 μM and about 85% dissoci-
ated at 10 μM. The result confirmed the former PP2A 
ubiquitination assay and explained why PP2A activ-
ity is upregulated by a low concentration of MCLR: 
the PP2A/C released from α4 regains catalytic activity 
and  thus  compensate  for  the  activity  loss.  The  hy-
pothesis was confirmed by probing PP2A/A from the 
immunoprecipitate. The interaction between PP2A A 
and C subunits showed a trend of 10% up-regulation 
in the 2 μM group. In the 10 μM group, a remarkable 
dissociation  of  core  enzyme  (AC)  was  seen;  only 
about 20% of PP2A/A remained bound to PP2A/C. 
The result is not only consistent with the drastic PP2A 
activity loss, but confirms the important function of α4 
in the assembly of the PP2A core enzyme, as recently 
reported  [16].  The  immunofluorescence  assay  was 
used to check the previous result by staining both α4 
and PP2A/C. Consistently, α4 and PP2A/C showed 
visibly abated co-localization (Fig. 3C), as α4 increas-
ingly located at nuclei, while PP2A/C kept locating 
mainly  at  cytoplasm.  We  conclude  from  these  data 
that α4 and PP2A/C dissociate under MCLR exposure 
and may cause the opposite changes of PP2A activi-
ties at different MCLR concentrations. 
MCLR destabilized HEK293 cells cytoskeleton  
We  next  studied  the  cellular  effect  brought  by 
the dissociation of α4 and PP2A/C. Because α4 is re-
ported to be essential for maintaining the stability of 
cytoskeleton architecture, especially regarding cellu-
lar actin polymerization and focal adhesion formation 
[19], we investigated the polymerization of actin and 
morphology of vinculin, an important focal adhesion 
protein. HEK293 cells were treated by 2 μM or 10 μM 
MCLR for 24 hours before immunofluorescence assay. 
As  shown  in  Fig.  4A,  decreased  polymerization  of 
actin was observed in 10 μM group. Moreover in 10 
μM group, vinculin localized in focal adhesion at cell 
extensions was decreased (Fig. 4B). While no obvious 
changes  were  observed  in  2  μM  group.  Given  the 
knowledge that α4 plays an important role in regu-
lating actin polymerization and focal adhesion, these 
data might suggest that the aggressive dissociation of 
α4 and PP2A/C might be related to the destabilization 
of cytoskeleton caused by MCLR.  
MCLR may induce anoikis in HEK293 cells  
Anoikis is a form of apoptosis induced by cell 
detachment  from  the  extracellular  matrix  [29].  Be-
cause α4 plays an essential role in opposing anoikis 
via  PP2A,  we  next  investigated  the  anoikis-related 
changes accompanied with  α4/PP2A/C dissociation 
after  MCLR  treatment.  Photos  were  taken  and  de-
tachment was measured by cell counting as described 
in Experimental Procedures (Fig. 5A, B). A trend of cell 
rounding was evident in the 10 μM group. Compared 
with  the  control  group,  cells  in  5  μM  and  10  μM 
groups  were  detached  by  the  wash  of  PBS  in  a 
dose-dependent  manner,  while  the  2  μM  group 
showed nearly no additional detachment. In the MTT 
assay,  we  found  the  vitality  of  cells  decreased  ac-
cordingly  to  the  detachment  assay,  as  statistically 
positive  vitality  decrease  was  shown  in  5  μM  and 
above  concentration  groups  (Fig.  5B).  Next,  we 
measured  several  proteins  important  to  anoikis  or 
apoptosis  (Fig.  6A).  Apoptotic  protein  Bad  upregu-
lated  its  protein  level,  while  anti-apoptotic  protein 
Bcl-2 decreased its protein level at high concentration 
MCLR  treatment;  the  full  length  of  caspase-3  re-
mained its protein level, while cleaved caspase-3 in-
creased  in  high  concentration  MCLR  groups,  as  a 
hallmark of anoikis/apoptosis induced by MCLR [30]. 
The previous immunofluorescence result of decreased 
focal  adhesion  formation  was  also  a  symptom  of 
anoikis  [31].  We  infer  from  these  data  that  MCLR 
causes  HEK293  cells  detachment  possibly  further 
anoikis.  
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Figure 3. MCLR triggers α4/PP2A C subunit dissociation and affects PP2A core enzyme stability. HEK293 cells were 
treated with MCLR at varying concentrations for 24 h. (A) The α4 protein level was examined by Western blotting, 
where GAPDH was used as loading control. (B) Immunoprecipitation assay was performed in HEK293 cell lysate using 
an anti-PP2A/C antibody. The association of PP2A/C with α4 and PP2A/A form precipitated material was detected by 
Western blotting. Binding of PP2A/A or α4 to PP2A/C was quantified and the ratio of each complex was measured by 
comparing to total C subunit and displayed by comparing to non-MCLR treated group. Data represent mean ±SD (n=3) 
*, p<0.05; ***, p<0.001 compared with control. (C) Immunofluorescence assay using antibody against PP2A/C and α4 
shows reduced binding between α4 (red) and PP2A/C (green). Nuclei (blue) were stained with DAPI. The merged 
images showed the co-localization of α4 and PP2A/C. 
 
Figure 4. MCLR destabilize HEK293 cells cytoskeleton. HEK293 cells were treated with MCLR at varying concen-
trations for 24 h before immunofluorescence assays. (A) F-actin (green) was stained with phallotoxins. (B) Vinculin 
(red) was stained with antibody against vinculin.  Int. J. Biol. Sci. 2011, 7 
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Figure 5. MCLR induces HEK293 cells morphology change, detachment and cell death. MCLR at varying concen-
trations was used to treat HEK293 cells for 24 h. (A) Microscope photos of live cells. Representative micrographs show 
morphological change of HEK293 cells in the 10 μM group. (B) Quantification of detachment and viability of HEK293 
cells following MCLR disposure. Data represent mean ±SD (n=3) *, p<0.05; **, p<0.01; ***, p<0.001 compared with 
control. 
 
 
 
 
Figure 6. MCLR induces changes of anoikis-related proteins. (A) HEK293 cells were treated by MCLR for 24 h and 
lysed. Protein level of Bad, Bcl-2, full length caspase-3 (35KDA) and cleaved caspase-3 (17 and 19KDA) were examined 
by Western blotting, where β-actin was used as loading control. Int. J. Biol. Sci. 2011, 7 
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Figure 7. Schematic representation of multiple cellular effects induced by low and high concentration of MCLR 
through α4 and PP2A. 
 
 
Table 1. Protein levels of different proteins after MCLR treatment. Densitometric analysis was performed by Image 
J software. Results were expressed by mean ±SD from three independent experiments. The protein expression from 
control group was designated as 1 and the others were expressed as folds compared with the control. In case of 
multiple bands, the values represent all bands detected. The asterisk symbol represents statistical significance in 
comparison with the control value (*, p<0.05; **, p<0.01). 
 
 
 
Discussion 
The  current  study  described  multiple  changes 
after  MCLR  treatment.  Importantly,  most  of  these 
effects are related to the function of α4 and the disso-
ciation  of  α4  and  PP2A/C.  At  low  concentration 
treatment, the partial dissociation of α4 and PP2A/C 
may  results  in  the  compensational  upregulation  of 
PP2A  activity.  At  high  concentration  MCLR  treat-
ment, the aggressive dissociation of α4 and PP2A/C 
may lead to the dissociation  of PP2A core enzyme, 
destabilization  of  cytoskeleton,  cell  detachment  and 
possibly further anoikis (Fig.7). 
MCs,  especially  MCLR  and  MCRR,  have  been 
known and utilized as PP2A inhibitors for decades. 
But the effect of MCs on PP2A in cell, especially at 
relatively low concentration, has seldom been stud-
ied. Our results, for the first time show that besides 
inhibition, MCLR at relatively low concentration can 
activate PP2A in cells. The nonlinear effect is charac-
teristic of hormesis, a dose-response phenomenon of 
by low-dose stimulation and high-dose inhibition. It 
has recently been reported that MCLR at low concen-
tration  stimulates  proliferation,  while  at  relatively 
high concentration decrease cellular viability, in an-
other kidney cell line, Vero-E6 cells. Such phenome-
non might seemingly resemble hormesis, though the 
term was not mentioned or proposed by the authors 
[26, 32].  Still,  whether  MCLR  could  cause  hormesis 
and if PP2A activity is a potential mark for hormesis Int. J. Biol. Sci. 2011, 7 
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detection  are  two  questions  needed  to  be  further 
studied. 
It is well established that the α4/PP2A/C com-
plex is inactive or has low catalytic activity [14-15]. In 
this study, the α4/PP2A/C complex compensates the 
loss of PP2A by dissociation at relatively low concen-
tration  of  MCLR.  Kong  and  colleagues  recently  re-
ported that α4 is essential for PP2A core enzyme as-
sembly and stability, and theorized that under cellular 
stress, the PP2A/C released from α4 is required for the 
adaptive  increase  in  PP2A  activity  [16].  Our  PP2A 
activity  assay  and  immunoprecipitation  results 
demonstrate  these  two  important  functions  of  α4. 
Further, we provide evidence of the relationship be-
tween the two seemingly diffuse functions: the dis-
ruption of the binding between α4 and C subunit in-
creases  PP2A  activity,  possibly  indicating  that  the 
released C subunit has shifted to the A subunit; on the 
other hand, α4 is essential for the stable binding of the 
PP2A A and C subunit. So does the dissociation of the 
α4/PP2A/C complex enhance or destabilize the core 
enzyme? In our data, the relatively low MCLR con-
centration results in partial α4/PP2A/C dissociation, 
which  may  yield  more  core  enzyme  and  increase 
PP2A activity. However, as the dissociation is aggra-
vated by a relatively high MCLR concentration, the 
PP2A core enzyme is disrupted and facilitates drastic 
PP2A  activity  loss  caused  by  MCLR.  Therefore,  we 
propose that partial dissociation of α4/PP2A/C could 
result in an adaptive increase of PP2A activity, but as 
the dissociation continues and crosses a certain limit, 
the core enzyme of PP2A becomes unstable. Certainly, 
we  could  not  rule  out  the  possibility  that  MCLR 
binding to PP2A/C directly disrupts the core enzyme. 
But because α4 is essential for core enzyme stability 
and  assembly,  it  is  more  likely  that  MCLR  affects 
PP2A core enzyme formation in this way.  
It is reported that α4 is important for maintaining 
cytoskeleton  architecture  and  opposing  anoi-
kis/apoptosis [19-20]. In our data, aggressive dissoci-
ation of α4 and PP2A/C at high concentration MCLR 
treatment also correlated with the destabilized cyto-
skeleton, cell detachment and possible anoikis. Given 
the major role α4 played in these cellular processes, 
we  propose  the  aggressive  dissociation  of  α4  from 
PP2A/C  renders  its  ability  to  maintain  cytoskeletal 
stability  and  cell  attachment,  and  further  opposing 
anoikis; while partial dissociation may still preserve 
most of these functions, like the proposed model of 
PP2A activity regulation. 
In addition to the dual effect on PP2A activity, 
we demonstrate in this study that MCLR affects the 
modification of PP2A/C protein. (i) The 1kDa up-shift 
of PP2A/C possibly suggests MCLR-conjunct band of 
PP2A/C, which may also be related with the inhibi-
tion  of  PP2A  activity.  (ii)  While  the  anti-p-PP2A/C 
antibody picks up both bands of PP2A/C, the relative 
strengths of the upper bands to lower bands observa-
bly increase with MCLR treatment. However, the an-
ti-methyl-PP2A/C antibody nearly does not recognize 
the upper band, with only a very slight band at high-
est  MCLR  concentration  group.  Such  phenomenon 
might suggest that phosphorylation of PP2A/C, ra-
ther  than  methylation  of  PP2A/C,  favors 
MCLR-conjunct band. (iii) The increase of phosphor-
ylated of PP2A/C is correlated with loss of PP2A ac-
tivity. Our date might thereby, provide evidence for 
the  cause-and-effect  relationship  between  the  two 
[33-34]. Since PP2A inhibition by MCLR is likely the 
more initial and direct cause of PP2A activity loss, our 
data  might  suggest  that  the  loss  of  PP2A  activity 
might  render  its  ability  to  reactivate  itself  by  auto-
dephosphorylation, as reported [34].  
The  results  of  the  present  study  suggest  that 
MCLR  triggers  a  compensation  in  PP2A  activity;  a 
former inactive complex of α4 and PP2A/C dissoci-
ates upon exposure to MCLR, and the newly released 
PP2A/C  may  overturn  the  inhibition  exerted  by 
MCLR. However, as the inhibition rises with a higher 
MCLR concentration, the released PP2A/C is limited 
for the full recovery of PP2A activity loss, and PP2A 
activity  decreases  aggressively.  Moreover,  we  find 
that the dissociation of α4 and PP2A/C is correlated 
with cytoskeleton destabilization, cell detachment and 
possible anoikis, which are preserved or opposed by 
α4. Thus the multiple cellular changes may also indi-
cate  the  consequences  followed  by  the  dissociation. 
Together, these results place α4 not only in the heart of 
PP2A activity regulation but also in an overall cellular 
response encountering MCLR in HEK293 cells. 
Biochemical  analysis  would  require  α4 
over-expression  and  knock-down  to  further  illumi-
nate the exact role of α4 in regulating PP2A and other 
cellular  processes  under  the  exposure  to  MCLR. 
However, considering the potential toxicity of trans-
fection, and the report that knock-down of α4 causes 
direct apoptosis, we stick to genetically un-modified 
cells. Nevertheless, our results for the first time show 
that MCLR at low concentration can stimulate cellular 
PP2A  activity,  and  further  illustrate  that  α4  and 
PP2A/C  dissociation  may  be  one  reason,  if  not  the 
only  reason,  contributed  to  this  unexpected  phe-
nomena.  
Recent studies of PP2A as a tumor suppressor 
have nudged it to the brink of being a potential target 
for cancer therapy [8, 35-36]. Increasing numbers of 
PP2A  activators  have  been  found,  such  as  FTY720, 
forskolin, ceramide and D-erythro-S [37-38], and some Int. J. Biol. Sci. 2011, 7 
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of them have been proposed for drug development 
without actually knowing the activation mechanism 
[36]. By contrast, MCLR has long been ruled out of 
such a list because of its similar inhibition on both PP1 
and PP2A activity (as shown in in vitro assay) . Here 
with PP2A activation induced by its very own inhib-
itor  MCLR  and  recently  reported  doxorubicin,  it  is 
possible that the in cell or in vivo influence of chemi-
cals on PP2A may not be as simple as what it shows in 
vitro. So far as the activation of PP2A is concerned, the 
compensation mechanism provides a hint for the un-
derstanding of a general PP2A activation mechanism. 
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Figure S1. Standard Curve from PP2A activity assays. 
Different  amount  of  free  phosphate  standard  from 
Promega  serine/threonine  phosphatase  assay  system 
were diluted and measured in 96-well plate, for the use 
of standard curve. 
 